Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Rascol

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Revue Neurologique|August 6, 2008
[Treatments in the early stage of Parkinson disease]O Rascol
European Journal of Neurology|January 25, 2011
Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-releaseO Rascol
Journal of Neural Transmission. Supplementum|May 21, 1999
Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?O Rascol
Revue Neurologique|January 16, 2010
[UPDRS scale is dead. Long live MDS-UPDRS!]O Rascol
Annals of Neurology|April 13, 2000
Medical treatment of levodopa-induced dyskinesiasO Rascol
Journal of Neurology|September 19, 2000
The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's diseaseO Rascol
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approachO Rascol
Revue Neurologique|March 27, 1999
[Arguments in favor of early treatment of Parkinson's disease with dopaminergic agonists]O Rascol
Brain Research|April 19, 1988
Differential effects of M1 and M2 muscarinic drugs on septohippocampal, hippocampal and cortical neurons in the ratO Rascol, Y Lamour
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1996
Methodological aspects in assessing antidementia drugsO Rascol, H Allain
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Revue Neurologique|August 6, 2008
[Treatments in the early stage of Parkinson disease]O Rascol
European Journal of Neurology|January 25, 2011
Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged-releaseO Rascol
Journal of Neural Transmission. Supplementum|May 21, 1999
Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?O Rascol
Revue Neurologique|January 16, 2010
[UPDRS scale is dead. Long live MDS-UPDRS!]O Rascol
Annals of Neurology|April 13, 2000
Medical treatment of levodopa-induced dyskinesiasO Rascol
Journal of Neurology|September 19, 2000
The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's diseaseO Rascol
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approachO Rascol
Revue Neurologique|March 27, 1999
[Arguments in favor of early treatment of Parkinson's disease with dopaminergic agonists]O Rascol
Brain Research|April 19, 1988
Differential effects of M1 and M2 muscarinic drugs on septohippocampal, hippocampal and cortical neurons in the ratO Rascol, Y Lamour
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1996
Methodological aspects in assessing antidementia drugsO Rascol, H Allain
Pageof 22